洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 Randomized Controlled Trial Comparing Open Reduction versus Ilizarov in the Management of AO Type C Pilon Fractures

【ChiCTR2000032800】Randomized Controlled Trial Comparing Open Reduction versus Ilizarov in the Management of AO Type C Pilon Fractures

查看原文
立即下载
基本信息
登记号

ChiCTR2000032800

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-05-11

临床申请受理号

/

靶点

/

适应症

Pilon骨折

试验通俗题目

Randomized Controlled Trial Comparing Open Reduction versus Ilizarov in the Management of AO Type C Pilon Fractures

试验专业题目

Randomized Controlled Trial Comparing Open Reduction versus Ilizarov in the Management of AO Type C Pilon Fractures

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

75510

联系人通讯地址
请登录查看
临床试验信息
试验目的

the aim of the study is to investigate the clinical effectiveness of ORIF versus Ilizarov for the management of Type C closed pilon fractures of the distal tibia

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

The patients were randomly allocated to either internal fixation or external fixation by a computer-generated sequence on a non-probability consecutive basis stratified by age and fracture type. Simple randomization was used in this study and delivered by a dedicated research officer to ensure that the allocation

盲法

Open label

试验项目经费来源

无

试验范围

/

目标入组人数

143;141

实际入组人数

/

第一例入组时间

2015-05-29

试验终止时间

2019-11-27

是否属于一致性

/

入选标准

The study included patients 18 years and older diagnosed with closed unilateral intraarticular pilon fracture of the distal tibia classified according to AO: AO 43 – C1, C2 and C3 (complete articular). Only unilateral fractures were included since problems may occur in rehabilitation with bilateral fractures which may compromise outcomes；

排除标准

The patients were excluded if they had a prior failed fixation; ipsilateral or contralateral lower limb fractures, dislocations, or both, pathological fracture; metabolic bone disease; or if the patient is/would be unable to understand instructions for treatment or was suffering from a mental illness, injury more than 21 days since injury, pre-existing (pre-injury) skin condition which precludes to open reduction and internal fixation or if the patient had multisystem injuries (polytrauma).；

研究者信息
研究负责人姓名
请登录查看
试验机构

Jinnah Postgraduate Medical Centre, Karachi, Pakistan

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

75510

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Jinnah Postgraduate Medical Centre, Karachi, Pakistan的其他临床试验

更多

巴基斯坦卡拉齐真纳教学医学中心研究生医学中心的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品